<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chang D</submitter><funding>Intramural NIH HHS</funding><funding>Parkinson's UK</funding><pagination>1511-1516</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5812477</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>49(10)</volume><pubmed_abstract>Common variant genome-wide association studies (GWASs) have, to date, identified >24 risk loci for Parkinson's disease (PD). To discover additional loci, we carried out a GWAS comparing 6,476 PD cases with 302,042 controls, followed by a meta-analysis with a recent study of over 13,000 PD cases and 95,000 controls at 9,830 overlapping variants. We then tested 35 loci (P &lt; 1 × 10-6) in a replication cohort of 5,851 cases and 5,866 controls. We identified 17 novel risk loci (P &lt; 5 × 10-8) in a joint analysis of 26,035 cases and 403,190 controls. We used a neurocentric strategy to assign candidate risk genes to the loci. We identified protein-altering or cis-expression quantitative trait locus (cis-eQTL) variants in linkage disequilibrium with the index variant in 29 of the 41 PD loci. These results indicate a key role for autophagy and lysosomal biology in PD risk, and suggest potential new drug targets for PD.</pubmed_abstract><journal>Nature genetics</journal><pubmed_title>A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci.</pubmed_title><pmcid>PMC5812477</pmcid><funding_grant_id>G-1307</funding_grant_id><funding_grant_id>Z99 AG999999</funding_grant_id><pubmed_authors>International Parkinson's Disease Genomics Consortium</pubmed_authors><pubmed_authors>Ayalon G</pubmed_authors><pubmed_authors>Singleton AB</pubmed_authors><pubmed_authors>Hunkapiller J</pubmed_authors><pubmed_authors>Hinds D</pubmed_authors><pubmed_authors>Cai F</pubmed_authors><pubmed_authors>Behrens TW</pubmed_authors><pubmed_authors>Bingol B</pubmed_authors><pubmed_authors>23andMe Research Team</pubmed_authors><pubmed_authors>Kerchner GA</pubmed_authors><pubmed_authors>Sheng M</pubmed_authors><pubmed_authors>Hallgrimsdottir IB</pubmed_authors><pubmed_authors>Chang D</pubmed_authors><pubmed_authors>Bhangale TR</pubmed_authors><pubmed_authors>Graham RR</pubmed_authors><pubmed_authors>van der Brug M</pubmed_authors><pubmed_authors>Nalls MA</pubmed_authors></additional><is_claimable>false</is_claimable><name>A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci.</name><description>Common variant genome-wide association studies (GWASs) have, to date, identified >24 risk loci for Parkinson's disease (PD). To discover additional loci, we carried out a GWAS comparing 6,476 PD cases with 302,042 controls, followed by a meta-analysis with a recent study of over 13,000 PD cases and 95,000 controls at 9,830 overlapping variants. We then tested 35 loci (P &lt; 1 × 10-6) in a replication cohort of 5,851 cases and 5,866 controls. We identified 17 novel risk loci (P &lt; 5 × 10-8) in a joint analysis of 26,035 cases and 403,190 controls. We used a neurocentric strategy to assign candidate risk genes to the loci. We identified protein-altering or cis-expression quantitative trait locus (cis-eQTL) variants in linkage disequilibrium with the index variant in 29 of the 41 PD loci. These results indicate a key role for autophagy and lysosomal biology in PD risk, and suggest potential new drug targets for PD.</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Oct</publication><modification>2021-02-19T23:22:28Z</modification><creation>2019-03-26T23:03:00Z</creation></dates><accession>S-EPMC5812477</accession><cross_references><pubmed>28892059</pubmed><doi>10.1038/ng.3955</doi></cross_references></HashMap>